Brief: Circio Ends TG01 Cancer Vaccine License Option Agreement
April 17 (Reuters) - Circio Holding ASA CRNA.OL :
* CIRCIO TERMINATES TG01 CANCER VACCINE LICENSE OPTION
AGREEMENT
WITH IOVAXIS IN CHINA FOR NON-PAYMENT
* SAYS DESPITE EXCHANGES WITH IOVAXIS, AGREED $300,000
DOWN-PAYMENT HAS NOT BEEN MADE AND NO PLAN HAS BEEN PROVIDED TO
DO SO
Source text for Eikon: ID:nObit9zz0a
Further company coverage: CRNA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration